| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.7B | $13.7B | $12.8B | $11.7B | $8.6B | $0.9B | $2.7B | — |
| Cost of Revenue | — | — | — | — | — | — | $2.2B | $2.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.9B | $1.3B | $1.0B | $1.1B | $0.2B | $-0.5B | $0.2B | $0.1B |
| Net Income | $1.3B | $1.2B | $0.8B | $0.4B | $0.0B | $-2.6B | $0.1B | $0.0B |
| EPS (Basic) | $10.32 | $9.39 | $5.50 | $2.24 | $-1.80 | $-2.89 | $0.52 | $0.11 |
| EPS (Diluted) | $9.81 | $8.95 | $5.31 | $2.17 | $-1.80 | $-2.89 | $0.52 | $0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.5B | $22.4B | $21.6B | $21.6B | $21.5B | $18.7B | $21.4B | $18.0B |
| Current Assets | $12.2B | $9.8B | $9.2B | $8.8B | $8.2B | $5.6B | $7.7B | $5.2B |
| Cash & Equivalents | $5.4B | $4.2B | $4.2B | $4.1B | $4.1B | $3.4B | $3.3B | $2.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $16.7B | $13.6B | $11.8B | $10.8B | $9.4B | $5.4B | $10.7B | $8.1B |
| Stockholders' Equity | $1.3B | $1.6B | $1.5B | $2.3B | $2.1B | $1.5B | $4.0B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.9B | $3.1B | $2.7B | $3.4B | $3.7B | $-3.8B | $2.8B | $2.0B |
| Investing Cash Flow | $-0.5B | $-1.3B | $-0.8B | $-0.6B | $-0.9B | $-0.3B | $-1.6B | $-0.6B |
| Capital Expenditures | $0.8B | $0.8B | $0.8B | $0.7B | $0.7B | $0.8B | $1.2B | $0.9B |
| Financing Cash Flow | $-2.1B | $-1.7B | $-2.1B | $-2.6B | $-1.0B | $4.1B | $0.2B | $-1.5B |